BrainXell
Business Services · Wisconsin, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
455 Science Dr Ste 210, Madison, Wiscons...Phone Number
(608) 220-3240Website
www.brainxell.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About BrainXell
BrainXell specializes in providing high-purity, iPSC-derived human neurons and glia aimed at advancing research and development in drug discovery. The company serves a diverse clientele, including over 75% of the world's largest pharmaceutical companies, by offering custom differentiation, iPSC reprogramming, and various assay services. Their mission is to enhance lives through scientific innovation, focusing on improving patient outcomes in CNS diseases. With a commitment to quality and expertise, BrainXell produces premier neuronal cell models tailored to meet the rigorous needs of researchers and scientists.Explore more
BrainXell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BrainXell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when BrainXell launches new products
Funding: Get notified immidiatlly once BrainXell has new funding data
Check if BrainXell has recently received funding, and reach out quickly before it becomes old news!
Click to see if BrainXell had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on BrainXell recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at BrainXell
BrainXell, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BrainXell is spiking on competitors!
Recommended Actions
Find VP level buyers at BrainXell
Find more new buyers
Compare Similar Companies to BrainXell
Compare insights from companies similar to BrainXell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BrainXell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BrainXell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BrainXell.
BrainXell Tech Stack
A closer look at the technologies used by BrainXell
Most Recent Scoops
Left Company
Executive Move
Shouming Du, Chief Executive Officer, has left the organization.
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Pain Point
Project
, according to a high-level source in Operations Management, is planning to remediate challenges related to capacity planning.
Pain Point, Capacity Planning, Facilities Management, Operations
Pain Point
Project
Pain Point, Contingent Workforce, Outsourcing, Workforce Management, Operations
BrainXell News & Media
BrainXell Launches Human iPSC-Derived Sensory Neurons for Translational Neuroscience and Pain Biology Research
MADISON, Wis., March 4, 2026 /PRNewswire/ -- BrainXell today announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineered to support reproducible functional studies in pain biology, sensory transduction, and...BrainXell Showcases Pioneering iPSC Research and Promising In Vivo Data for BXT-110 for Parkinson's Disease at the 2025 Society for Neuroscience Annual Meeting
SAN DIEGO, Nov. 15, 2025 /PRNewswire/ -- BrainXell, Inc. today announced that data will be presented during poster sessions at the 2025 Society for Neuroscience (SfN) Annual Meeting in San Diego, highlighting new breakthroughs in human iPSC-derived cell models and regenerative...BrainXell Therapeutics Unveils Promising Preclinical Data Demonstrating Efficacy of BXT-110, an Autologous iPSC-Derived Neuronal Therapy, in Parkinson's Disease
SAN DIEGO, Nov. 3, 2025 /PRNewswire/ -- BrainXell Therapeutics today announced the disclosure of its first scientific data, which will be presented at two conferences this month: the Cell Symposia | Gene and Cell-Based Therapies: Progress in Clinical Translation and the Society for...BrainXell, Inc. Strengthens Executive Leadership with Paul Marcus and Dr. Su-Chun Zhang
MADISON, Wis., July 17, 2025 /PRNewswire/ -- BrainXell, a leading producer of iPSC-derived human neurons and glia, is proud to announce the continued growth of its executive leadership team with the appointment of Paul Marcus as President, Chief Operating Officer, Chief Financial Officer...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BrainXell
Sign Up For FreeTo access detailed company insights
BrainXell specializes in providing high-purity, iPSC-derived human neurons and glia aimed at advancing research and development in drug discovery. The company serves a diverse clientele, including over 75% of the world's largest pharmaceutical companies, by offering custom differentiation, iPSC reprogramming, and various assay services. Their missi... Read More
